Uli Alf Hacksell

Directeur/Membre du Conseil chez ACTIVE BIOTECH AB

Profil

Uli Alf Hacksell is currently an Independent Director at Active Biotech AB since 2019, a Director at Medivir AB since 2018, and a Director at Beactica Therapeutics.
Formerly, the roles included President, CEO, Director & Accounting Officer at ACADIA Pharmaceuticals, Inc. from 2014 to 2015, Chief Executive Officer at Acadia Pharmaceuticals AB from 2000 to 2015, Chairman at Action Pharma A, European Federation for Medicinal Chemistry, Adhera Therapeutics, Inc. from 2018 to 2020, Glionova AB, SynAct Pharma ApS, SynAct Pharma AB from 2023 to 2024, Annexin Pharmaceuticals AB, and Beactica Therapeutics AB. Other former positions include Director at Avalo Therapeutics, Inc. from 2019 to 2020, Independent Director at InDex Pharmaceuticals AB and Flerie AB, Vice President-Drug Discovery & Technology at Astra AB from 1991 to 1999, Professor at the University of Uppsala, President at Astra Draco AB, and VP-CNS Preclinical Research & Development at Astra Arcus AB in 1994.
Education includes a doctorate from the University of Uppsala.

Postes actifs de Uli Alf Hacksell

Sociétés	Poste	Début
MEDIVIR AB	Directeur/Membre du Conseil	-
ACTIVE BIOTECH AB	Directeur/Membre du Conseil	23/05/2019
Beactica Therapeutics	Directeur/Membre du Conseil	-

Anciens postes connus de Uli Alf Hacksell

Sociétés	Poste	Fin
SYNACT PHARMA AB	Président	20/03/2024
ADHERA THERAPEUTICS, INC.	Président	10/07/2020
AVALO THERAPEUTICS, INC.	Directeur Général	14/08/2017
Glionova AB	Président	01/01/2017
ACADIA PHARMACEUTICALS INC.	Directeur Général	11/03/2015